Clinical Trial Update: Comparison of Insulin Detemir and NPH Insulin Given Once Daily in Ageing Subjects With Type 2 Diabetes [Phase 4]

View source ↗

Summary

Phase 4 trial comparing once-daily insulin detemir vs NPH insulin in older adults with type 2 diabetes; study terminated with results posted in 2010.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Insulin detemir (insulin detemir)
• NPH insulin (insulin isophane)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Diabetes, Diabetes Mellitus, Type 2 | Phase 4 | Status: TERMINATED | Results posted: 2010-11-17